Central Alerting System
View Alert


Originator: DHSC Supply Disruption Alert

Issue date: 14-Jun-2019 13:00:04

This alert has been issued to:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • NHS Regional Offices
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities Trusts
  • Acute Trusts
  • Community Trusts

  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • Social Care Providers (registered with CAS)
  • Special Health Authorities
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Director of Public Health

Action category: Immediate Action

Title: Disopyramide 100/150mg capsules - supply disruption

Broadcast content:
Disopyramide 100mg capsules manufactured by Sanofi and Mylan will be out of stock from approximately mid-June 2019 to late-July 2019.

Mylan disopyramide 150mg capsules will be out of stock from approximately mid-August 2019 till mid-September 2019. 

This alert gives advice for all healthcare professionals who prescribe and dispense disopyramide capsules. This alert also makes reference to supply via specialist importers on an ‘unlicensed’ basis.


Additional information: NHS Regional Offices: please cascade to GPs and Pharmacy.

Alert reference: SDA/2019/002

Action underway deadline: 18-Jun-2019

Action complete deadline: 30-Sep-2019

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency